Bio Green Med Solution, Inc. (BGMS)
0.88
0.00 (0.00%)
USD |
NASDAQ |
Oct 05, 16:00
0.88
0.00 (0.00%)
After-Hours: 20:00
Bio Green Med Solution EPS Diluted (Quarterly) : -0.0759 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0759 |
| March 31, 2026 | -0.0398 |
| December 31, 2025 | -2.208 |
| September 30, 2025 | -1.309 |
| June 30, 2025 | -0.9834 |
| March 31, 2025 | -13.77 |
| December 31, 2024 | -82.63 |
| September 30, 2024 | -0.9093 |
| June 30, 2024 | -1.804 |
| March 31, 2024 | -2.27 |
| December 31, 2023 | -6.230 |
| September 30, 2023 | -7.216 |
| June 30, 2023 | -6.570 |
| March 31, 2023 | -7.003 |
| December 31, 2022 | -2144.66 |
| September 30, 2022 | -6.268 |
| June 30, 2022 | -6.844 |
| March 31, 2022 | -6.241 |
| December 31, 2021 | -8.146 |
| September 30, 2021 | -8.065 |
| June 30, 2021 | -8.410 |
| March 31, 2021 | -7.455 |
| December 31, 2020 | -20.17 |
| September 30, 2020 | -7.112 |
| June 30, 2020 | -8.633 |
| Date | Value |
|---|---|
| March 31, 2020 | -22.15 |
| December 31, 2019 | -41.06 |
| September 30, 2019 | -34.03 |
| June 30, 2019 | -31.97 |
| March 31, 2019 | -41.62 |
| December 31, 2018 | -51.00 |
| September 30, 2018 | -52.96 |
| June 30, 2018 | -47.56 |
| March 31, 2018 | -34.98 |
| December 31, 2017 | -52.14 |
| September 30, 2017 | -273.00 |
| June 30, 2017 | -150.00 |
| March 31, 2017 | -114.00 |
| December 31, 2016 | -203.61 |
| September 30, 2016 | -258.00 |
| June 30, 2016 | -301.48 |
| March 31, 2016 | -324.00 |
| December 31, 2015 | -360.00 |
| September 30, 2015 | -288.00 |
| June 30, 2015 | -360.00 |
| March 31, 2015 | -684.00 |
| December 31, 2014 | -756.00 |
| September 30, 2014 | -792.00 |
| June 30, 2014 | -792.00 |
| March 31, 2014 | -900.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Supermax Corp. Bhd. | 0.0065 |
| YD Bio Ltd. | -0.6496 |
| ALPS Group, Inc. | -0.2355 |
| Cencora, Inc. | 3.937 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.405M |
| Revenue (Quarterly) | 0.336M |
| Total Expenses (Quarterly) | 0.741M |
| Enterprise Value | 2.038M |
| Gross Profit Margin (Quarterly) | 23.51% |
| Profit Margin (Quarterly) | -120.5% |
| Earnings Yield | -412.7% |
| Normalized Earnings Yield | -412.73 |